Biotech & Genetics · Projected milestone
AI-designed proteins in industry
Estimated year~2027
92% by 2032 · including earlier years
The year is an editorial timing estimate. The percentage applies to occurrence by the stated deadline. These estimates are not calibrated odds.
Custom enzymes and binders designed by AI enter medicine and manufacturing.
Explore this milestone on the interactive mapWhat the forecast means
Milestone stage: milestone (legacy definition)
Completion criteria: Legacy milestone: refine the observable threshold before resolving.
This page describes a forecast, rather than an achieved result. Read the methodology and assumptions.
Built on
Led to
- Enzymatic plastic recycling plantsForecast · ~2028enables
- AI food scientistForecast · ~2029enables
- Medical nanorobotsForecast · ~2032enables
- Switchable drugsForecast · ~2032requires
- Chromosome-scale DNA writingForecast · ~2035enables
- Universal flu vaccineForecast · ~2036enables
- Universal DNA-synthesis screeningForecast · ~2040enables
- Microbes make bulk chemicalsForecast · ~2042enables
- Living artworksForecast · ~2045enables
- Molecular manufacturingForecast · ~2048enables
- Kitchen bin that digests plasticForecast · ~2054enables
- Tooth-repair mouthguardForecast · ~2054enables
- Cell designed from scratchForecast · ~2056enables
- Mirror-image peptide drugsForecast · ~2060enables
- Brand-new tastes and texturesForecast · ~2065enables
- Universal antidote penForecast · ~2070enables
Sources & evidence
No individual source links are recorded for this milestone. Source coverage and review status vary across the atlas.
Dataset updated 2026-10-18. This individual record has not been separately re-reviewed.